NVACU
Northview Acquisition Corporation
A maker of tiny injectable biosensors that sit under the skin and continuously track the body's internal chemistry, such as oxygen and glucose, without any internal electronics—a wearable reader shines light into the tissue to take readings. Originally formed in New York as a blank-check company (a SPAC) in 2021 to hunt for a healthcare-technology business, it later merged with Profusa, a digital health company, and took on that name. The sensors are made of a smart hydrogel similar to soft contact lenses, and the body's own tissue grows into them so they can work for months to years.
UNITUnderlying: NVACCUSIP: 66718N202FinancialsUS1 holder
Unit consisting of one share of common stock, one right, and one-half warrant — Delisted from Nasdaq December 27, 2024
Recent Activity
2022Q1
1 sell
-750.0K shares
-750.0K shares
Loading more activity...